Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Mitoxantrone Followed by Rebif 44 mcg in Early Multiple Sclerosis
2004-001601-10Phase 3Terminated
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Mar 2007
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of mitoxantrone and interferon beta-1a in multiple sclerosis (MS) (2 arms), sponsored by IRCCS Ospedale San Raffaele. Started Mar 2007; status: terminated.
02
Drugs
mitoxantroneinterferon beta-1a
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2004-001601-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001601-10.